Dr. Barry Dworkin

Glp-1 medications like semaglutide (Ozempic, Wegovy)) and Tirzepatide (Mounjaro, Zepbound) are designed for long-term use to treat chronic disease/conditions. What happens if people go on and off them?

Medical Mythbusting Commentary for October 30, 2026

Source:
Everyone’s going on — and off — GLP-1s. What’s that doing to your health?

Related posts:

  1. Unpublished sugary drink study uses statistical manipulation to claim link to 180,000 yearly deaths
  2. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment
  3. Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.
  4. Battle With Heart Disease Moves to the Doctor's Office but what about the grocery store?